HOME
SEARCH
RSS FEED
SUBSCRIBE
Repurposing CDK Inhibitors for the Treatment of Zika Virus Infection
Case ID:
TAB-3599
Web Published:
12/6/2022
Description:
This invention includes the discovery and use of a group of CDK inhibitors that were found during a drug repurposing screen designed to find compounds that inhibit Zika virus caused cell death. The identified CDK inhibitors have all previously been used in clinical trials for other diseases, potentially reducing the long time course needed for new drug discovery and development.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Direct Link:
https://nih.technologypublisher.com/tech/Repurposing_CDK_Inhibitors_for_the_T reatment_of_Zika_Virus_Infection
Category(s):
Neurology
Therapeutics
Infectious Disease
Research Materials
Bookmark this page
Download as PDF
For Information, Contact:
Suryanarayana Vepa
Deputy Director; OSA
NIH Technology Transfer
301-827-7181
sury.vepa@nih.gov
Inventors:
Ruili Huang
Miao Xu
Wenwei Huang
Hengli Tang
Emily Lee
Cheng YiChen
Yi Zhou
Hongjun Song
Guo-Li Ming
Zhexing Wen
Wei Zheng
Keywords:
CDK
Infection
Inhibitors
Repurposing
treatment
VEXXXX
virus
VLXXXX
WIXXXX
WKXXXX
Zika
Home
|
Search
|
RSS
|
Subscribe
© 2025. All Rights Reserved. Powered by
Inteum